Inducible innate resistance of lung epithelium to infection.
about
SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infectionPneumonia in the neutropenic cancer patientMucociliary clearance: pathophysiological aspectsInterferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.Response of Differentiated Human Airway Epithelia to Alcohol Exposure and Klebsiella Pneumoniae ChallengeSynergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumoniaInhaled innate immune ligands to prevent pneumonia.Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices.Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune SystemAirway mucus function and dysfunction.Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced diseasePresence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients.Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.Pharmacologic activation of the innate immune system to prevent respiratory viral infections.Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammationA Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections.Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.CCL20 and Beta-Defensin 2 Production by Human Lung Epithelial Cells and Macrophages in Response to Brucella abortus Infection.Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract.Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guérin.SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasiaDual oxidase 2 bidirectional promoter polymorphisms confer differential immune responses in airway epithelia.Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response.Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infectionRefractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compoundSynergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice.Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs.Magnetic Nanodrug Delivery Through the Mucus Layer of Air-Liquid Interface Cultured Primary Normal Human Tracheobronchial Epithelial Cells.Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands.Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.How the genetics of lung cancer may overlap with COPD.Control of innate immunity by memory CD4 T cells.Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro.Staphylococcus aureus hemolysin A disrupts cell-matrix adhesions in human airway epithelial cells.
P2860
Q24336522-3396F479-185C-4A2F-A266-8D848510E55FQ26827758-143D03CE-9C77-4586-97BB-1532DE1CB781Q27022272-77F448A3-6BAC-48E2-A41E-31056AAB24ABQ27312575-585163F6-A24E-4243-913A-41AE76EF6CC2Q28383555-6D26DA06-4FA5-4C86-B63D-63C8F3840F89Q28732374-C5460393-C0B9-494C-BA1F-6AED19B4BC18Q30398752-8B74C397-1513-44AA-9A89-18EF2877A0E0Q33612279-983920D6-359D-4C11-895F-C2AB09B4A708Q33664362-A49D8CF4-76D7-424F-9B1E-16CECC5D5A5EQ33723578-15EA88D3-F17C-4198-99BA-BC882AB9B9D8Q34066406-15F05E85-C5BC-4E64-946D-A19A2B8D82E3Q34149169-833C242F-6E70-466C-8068-3FBA85033893Q34505776-496CFB6B-A5F0-4FAB-9CA1-8A460876D22EQ34621087-60ED0201-945B-4A69-8944-13C81E577C64Q35196768-0D82E933-D1C0-496D-A35A-DE9F6B08B3EBQ35494999-27CC4DAB-B2D8-411D-829A-76FAABDB006DQ35692082-28A33AC0-2822-4848-A394-63666A93BC7EQ36023838-3BB7D613-49F5-4872-A34E-E18AAF3DB805Q36040700-0C1A957F-89B5-4687-89AC-DB6917FE1677Q36075829-47073C2A-D147-4029-B08B-6FBFB2936C24Q36076086-83384029-C23B-43CA-A3CC-835290C028C2Q36136937-6235AF64-B49A-4626-9151-10EA301772ADQ36158691-5548BAD1-9A43-4461-BA3A-819ECB78579DQ36159388-913AE62D-EF59-4F9D-92EA-345BC9E2566CQ36339871-4C9C824C-B13D-4AF2-A274-3667BE73E64BQ36369935-49F1DD04-F8E9-48A1-8FFC-C1424A2A4104Q36698336-2B6C72D1-A3C2-4E62-BA20-D2C2E57937EDQ36717803-7BEB5A00-F906-4021-96A2-E955CE935E29Q36839796-AE5ED103-0D2F-4051-8A5C-FE3F18E35120Q36845161-7198956D-8816-4C79-B311-B68AE2D23198Q37056423-D6BCE374-76E5-4298-9DA0-5935A5DE61CEQ37350756-68046C5F-D89B-4B16-9CE9-A342A7DE2609Q37558881-D4EABBB0-43B6-43FF-A519-292E8D34F508Q37568931-B871A8EE-5FA6-446C-9AE1-75D9FB5FEB56Q37900349-97340398-46AE-4E0F-9A07-22F8744F8120Q37917679-9DAF0B3B-17F4-46DA-A179-33C746491E0FQ38051328-9D1D78EC-3BDB-4532-B6DF-E3A986F2B75AQ38195597-FEF96CF3-A837-40DF-AC31-A39663487307Q38972117-2C5B587D-87E9-47A7-B0CA-DC3255B799CEQ38985913-89ACC408-E21C-4476-AE84-1FB3D5794AAE
P2860
Inducible innate resistance of lung epithelium to infection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Inducible innate resistance of lung epithelium to infection.
@ast
Inducible innate resistance of lung epithelium to infection.
@en
type
label
Inducible innate resistance of lung epithelium to infection.
@ast
Inducible innate resistance of lung epithelium to infection.
@en
prefLabel
Inducible innate resistance of lung epithelium to infection.
@ast
Inducible innate resistance of lung epithelium to infection.
@en
P2093
P2860
P1476
Inducible innate resistance of lung epithelium to infection.
@en
P2093
Burton F Dickey
Michael J Tuvim
Scott E Evans
P2860
P304
P356
10.1146/ANNUREV-PHYSIOL-021909-135909
P577
2010-01-01T00:00:00Z